Publications
Specialty
Search
Rheumatology & Arthritis
08/28/2024
Active enthesitis was consistently linked with most clinical measures of spondyloarthritis disease activity and severity.
EP Lab Digest
08/27/2024
AtriCure, Inc., Press Release
EP Lab Digest
08/27/2024
OMRON Healthcare Press Release
Psych Congress Network
08/27/2024
People with polycystic ovarian syndrome (PCOS) could be more at risk for eating disorders than people without PCOS, according to recent results from a review and meta-analysis published in the Journal of Clinical Endocrinology & Metabolism.
First Report Managed Care
08/27/2024
The authors explore the advantages of timely transfers of critically ill patients to Kindred Hospitals, a national network of long-term acute care hospitals (LTACHs), providing insights into key aspects of their intensive care units (ICUs).
Annals of Long-Term Care
08/27/2024
Globus pallidus internus (GPi) activity in patients with Parkinson’s disease (PD) was strongly modulated by circadian rhythms, according to a study published in Nature Communications.
EMSWorld
08/27/2024
EMS workers not only experience mental, physical, and emotional stress, but also sleep deprivation. What kind of health challenges—both cognitive and behavioral—can this lead to?
EP Lab Digest
08/27/2024
PaceMate Press Release
Psych Congress Network, Neurology
08/27/2024
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
Wound Management & Prevention
08/27/2024
Bin Traiki Thamer, MBBS1; Fayez Aldarsouni, MBBS2; Razan AlRabah, MBBS3; Hassan Aloraini, MBBS4; Esraa Altawil, SSCPN5; Doaa Alfraidy, MBBS6, 7; Sulaiman Alshammari, MBBS1; Noura Alhassan, MBBS
Oncology
08/27/2024
Myron Czuczman, MD, discusses Pivotal Study 302, which led to the FDA approval of denileukin diftitox for the treatment of patients with relapsed/refractory cutaneous T-cell lymphoma.
Neurology, Psych Congress Network
08/27/2024
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
Pharmacy Learning Network
08/27/2024
True or False: Lecanemab is the first Alzheimer's drug to successfully affect the course of the disease in phase 3 trials and receive full FDA approval.
Podiatry Today
08/27/2024
In this episode, Dr. Rader dives into the latest research, including key information on extracellular matrices.
Gastroenterology
08/27/2024
CAD-EYE detection system significantly improved the number of adenomas detected per colonoscopy without extending the procedure time, according to a recent report.
Wound Care
08/26/2024
A 216-patient RCT will evaluate the efficacy and safety of ExcharEX in the debridement of VLUs with the primary outcome of complete debridement at 2 weeks and complete wound closure at 12 weeks. Not yet recruiting; with estimated study completion in Oct 2026. clinicaltrials.gov
Psych Congress Network
08/26/2024
Downloadable resource designed to help assess ongoing ADHD symptoms that may signal a need for a treatment plan transition.
Wound Care
08/26/2024
BioStem has registered a 60-patient study to evaluate the safety and efficacy of human placental allograft BR-AM (Vendaje) + SoC vs SoC only in the treatment of DFUs. Primary outcome measures 100% re-epithelialization over a 12-week period. Est study completion 1/26. clinicaltrials.gov
Wound Care
08/26/2024
A study of 50 patients who underwent MRM because of breast cancer and were at high risk of wound site complications found that the iNPWT group had reduced post-op seroma, flap ischemia, and flap dehiscence compared to conventional dressings. Asian J Surg
Wound Care
08/26/2024
A 124-patient RCT will investigate the efficacy of single-layer amniotic membrane (XWRAP) and SoC vs. SoC alone for closure of non-healing DFUs with the primary outcome of percent of wound closure in 12 weeks. Not yet recruiting; estimated study completion is Aug 2025. clinicaltrials.gov